Bright Minds Biosciences (DRUG) Receivables Refunds (2021 - 2026)

For the quarter ending Q1 2026, Receivables Refunds rose 1056.6% year-over-year to $36173.7, compared with a TTM value of $36173.7 through Mar 2026, up 1056.6%, and an annual FY2025 reading of $152533.8, up 314.3% over the prior year.

Bright Minds Biosciences (DRUG) has disclosed Receivables Refunds for 6 consecutive years, with $36173.7 as the latest value for Q1 2026.

  • Receivables Refunds reached $36173.7 in Q1 2026 per DRUG's latest filing, down from $152533.8 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $152533.8 in Q3 2025 and bottomed at -$3781.5 in Q1 2025.
  • Average Receivables Refunds over 5 years is $56189.1, with a median of $36495.3 recorded in 2024.
  • Year-over-year, Receivables Refunds tumbled 68.58% in 2023 and then skyrocketed 1056.6% in 2026.
  • Bright Minds Biosciences' Receivables Refunds stood at $87806.2 in 2022, then plummeted by 68.58% to $27585.3 in 2023, then soared by 33.47% to $36816.9 in 2024, then skyrocketed by 314.3% to $152533.8 in 2025, then plummeted by 76.28% to $36173.7 in 2026.
  • Per Business Quant, the three most recent readings for DRUG's Receivables Refunds are $36173.7 (Q1 2026), $152533.8 (Q3 2025), and -$3781.5 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Refund Receivables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Bright Minds Biosciences 464.72 Mn 405.19 Mn - 36,173.71

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36,173.71
Dec 31, 2025 -21,917.03
Sep 30, 2025 152,533.77
Jun 30, 2025 -46,870.90
Mar 31, 2025 38,783.40
Dec 31, 2024 12,024.12
Sep 30, 2024 36,816.87
Jun 30, 2024 14,436.37
Mar 31, 2024 18,762.11
Dec 31, 2023 5,919.62
Sep 30, 2023 27,585.25
Jun 30, 2023 8,071.35
Mar 31, 2023 60,030.06
Dec 31, 2022 40,697.68
Sep 30, 2022 87,806.25
Jun 30, 2022 35,853.00
Mar 31, 2022 -52,308.27
Dec 31, 2021 -31,371.68
Sep 30, 2021 87,501.01
Jun 30, 2021 -63,442.10
Mar 31, 2021 28,645.83